Compare Bundamedik Tbk (BMHS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Bundamedik Tbk is far larger — about 9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bundamedik Tbk is more actively traded (536.7K versus 71K). Which is the better fit depends on your goals.
| BMHS | OBAT | |
|---|---|---|
Market Cap | 1.51T | 167.37B |
Volume | 536.7K | 71K |
Lot | 5.37K | 710 |
Turnover | 93.41M | 17.51M |
Average Price | 174.05 | 246.63 |
Value | 93.41M | 17.51M |
Indicative Equilibrium Price | 176 | 246 |
Indicative Equilibrium Volume | 100 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
